Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients.

In order to determine the clinical impact of Klebsiella bacteremia on critically ill patients, a matched cohort study was conducted between January 1992 and December 2000. During the study period, all intensive care unit (ICU) patients with nosocomial Klebsiella bacteremia were defined as cases (n=52), but two of these patients were excluded from the matched cohort due to incomplete medical records. The remaining 50 patients were matched at a ratio of 1:2 with control patients (n=100) on the basis of the APACHE II severity of disease classification system. Patients with Klebsiella bacteremia experienced acute renal failure and hemodynamic instability more often than controls. They also had a longer ICU stay and longer ventilator dependence. In-hospital mortality rates for cases and controls were nearly equal (36% vs. 37%, respectively; P=0.905). In conclusion, after adjusting accurately for severity of underlying disease and acute illness, no difference in mortality was found between ICU patients with Klebsiella bacteremia and their matched control subjects.

Cytokine removal during continuous hemofiltration in septic patients.

A potential application of the continuous renal replacement therapies is the extracorporeal removal of inflammatory mediators in septic patients. Cytokine elimination with continuous renal replacement therapies has been demonstrated in several clinical studies, but so far without important effects on their serum concentrations. Improved knowledge of the cytokine removal mechanisms could lead to the development of more efficient treatment strategies. In the present study, 15 patients with septic shock and acute renal failure were observed during the first 24 h of treatment with continuous venovenous hemofiltration (CVVH) with an AN69 membrane. After 12 h, the hemofilter was replaced and the blood flow rate (QB) was switched from 100 ml/min to 200 ml/min or vice versa. Pre- and postfilter plasma and ultrafiltrate concentrations of selected inflammatory and anti-inflammatory cytokines were measured at several time points allowing the calculation of a mass balance. Cytokine removal was highest 1 h after the start of CVVH and after the change of the membrane (ranging from 25 to 43% of the prefilter amount), corresponding with a significant fall in the serum concentration of all cytokines. The inhibitors of inflammation were removed to the same extent as the inflammatory cytokines. Adsorption to the AN69 membrane appeared to be the main clearance mechanism, being most pronounced immediately after installation of a new membrane and decreasing steadily thereafter, indicating rapid saturation of the membrane. A QB of 200 ml/min was associated with a 75% increase of the ultrafiltration rate and a significantly higher convective elimination and membrane adsorption than at a QB of 100 ml/min. The results indicate that optimal cytokine removal with CVVH with an AN69 membrane could be achieved with a combination of a high QB/ultrafiltration rate and frequent membrane changes.

Pitfalls in the diagnosis of hypereosinophilic syndrome: a report of two cases.

The idiopathic hypereosinophilic syndrome is empirically defined as the presence of prolonged eosinophilia without identifiable underlying cause, and with evidence of end-organ dysfunction. Virtually any organ system may be involved, most frequently the heart, the central and peripheral nervous system, the lungs and the skin. We report two cases where the diagnosis of hypereosinophilic syndrome was proposed although the classic criteria were not met. In the first case total peripheral eosinophil counts were relatively low, but pathological evidence clearly showed infiltration of eosinophils in the damaged tissues. An hypothesis to explain this discrepancy is formulated. The second case did not fulfil the first feature either, although the clinical presentation and disease course corresponded well with other cases reported in the literature. The delay in diagnosis was caused by early institution of corticosteroids, clearing all evidence of eosinophil involvement in the observed tissue damage.

Evaluation of transesophageal echocardiography as a diagnostic and therapeutic aid in a critical care setting.

OBJECTIVES: To assess the impact of transesophageal echocardiography (TEE) on therapeutic management in relation to pulmonary artery catheterization (PAC) in the ICU. DESIGN: Retrospective analysis of 108 consecutive TEE video and related patient files during a 7-month period. SETTING: A 33-bed medical and surgical ICU. METHODS: All critically ill patients with or without PAC in whom a TEE was performed, excluding postoperative cardiac surgical patients. Patients were divided in a cardiac and a septic group depending on the primary disease on admission to the ICU. The impact of TEE in relation to PAC on ICU management was evaluated in whether therapy changes were performed strictly on the basis of the TEE findings. MAIN RESULTS: Of 64% of patients with a PAC, 44% underwent therapy changes after TEE: 41% in the cardiac and 54% in the septic subgroup. In 41% of patients without a PAC, TEE led to a change in therapy. CONCLUSIONS: TEE results in altered therapeutic management in at least one third of our (noncardiac surgery) ICU patient population independent of the presence of a PAC.

Doppler evaluation of right ventricular outflow impedance during positive-pressure ventilation.

Positive-pressure ventilation has often been advocated to increase oxygen delivery. This ventilation mode itself, however, can impair right ventricular ejection and, thus, diminish cardiac output. In this study, alterations of right ventricular outflow impedance were evaluated after stepwise increases of positive end-expiratory pressure (PEEP). Different pulmonary artery flow characteristics were evaluated with transesophageal echocardiography in mechanically ventilated postoperative coronary artery bypass surgery patients without pulmonary hypertension. A progressive decrease of pulmonary artery flow velocity and time velocity integrals was found with increasing PEEP levels. No changes in acceleration time or pre-ejection period were observed. In order to decrease the influence of heart rate, the ratios of the different pulmonary artery flow characteristics were calculated. At end-inspiration, both the ratio of acceleration time to right ventricular ejection period and the ratio of pre-ejection period to right ventricular ejection period showed progressive increases above 10 cmH2O positive end-expiratory pressure (13.3% at the level of 15 cmH2O and 8.5% at the level of 20 cmH2O). In this study, acceleration time appears not to be of importance in ventilated patients. These data strongly support the hypothesis that intermittent squeezing of the pulmonary arterial tree during inspiration, rather than positive end-expiratory pressure, creates an increase of right ventricular outflow impedance.

Acute hemodynamic changes of pressure-controlled inverse ratio ventilation in the adult respiratory distress syndrome. A transesophageal echocardiographic and Doppler study.

Twelve patients with the adult respiratory distress syndrome were included in this study and evaluated by transesophageal echocardiography and Doppler, assessing right and left ventricular intracardiac blood flow alterations with progressive increase of inspiration-to-expiration (I-E) ratios. Whereas midpulmonary artery flow parameters did not show any change, early left ventricular filling demonstrated a significant increase after switching the ventilatory mode from volume to pressure-controlled ventilation with 2:1 I-E ratio (end-inspiration: 39 +/- 26 cm with positive end-expiratory pressure [PEEP]-ventilation to 68 +/- 56 cm with pressure-controlled inverse-ratio ventilation, 2:1; p < 0.01; at end-expiration, from 67 +/- 21 cm with PEEP-ventilation to 83 +/- 36 cm with pressure-controlled ventilation 1:1; p < or = 0.05), resulting probably from different ventilatory flow and pressure curves. In the meanwhile, cardiac index demonstrated a significant augmentation (from 4.73 +/- 1.71 L/min.m2 to 5.56 +/- 1.66 L/min.m2; p < 0.05). Pressure-controlled inverse ratio ventilation results in both respiratory and hemodynamic advantages as is demonstrated by this study.

Penetration of netilmicin in the lower respiratory tract after once-daily dosing.

A major criticism of the use of aminoglycosides for the treatment of pneumonia is the poor penetration in infected airways. Once-daily dosing of aminoglycosides results in higher peak plasma concentrations without increasing toxic reactions and with optimization of pharmacodynamic properties. To predict intrapulmonary antimicrobial activity after once-daily dosing of aminoglycosides, it is necessary to determine the respective bronchial and alveolar disposition. We prospectively conducted a pharmacokinetic study of netilmicin following the first intravenous administration of a once-daily dosing schedule in 20 ventilated patients with pneumonia. A bronchoscopic sampling of bronchial secretions and a subsegmental bronchoalveolar lavage (BAL) were performed 60, 90, 120, and 180 min (five patients at each time point) on the first treatment day after intravenous administration over 30 min of 450 mg of netilmicin. The netilmicin concentrations in the alveolar lining fluid (ALF) were calculated using urea as an endogenous marker of dilution. In bronchial secretions, a peak concentration of 2.00 (SEM: 0.26) mg/L or 6 percent of the 30-min plasma concentration was reached at 120 min. In ALF, much higher levels were found. At 120 min, a peak ALF concentration of 14.7 (SEM: 2.22) mg/L or 41 percent of the 30-min plasma concentration was reached. Spearman's rank correlation testing failed to show a correlation between bronchial and ALF concentrations. Higher plasma concentrations of netilmicin after once-daily dosing give rise to ALF concentrations exceeding the minimum inhibitory concentration of susceptible respiratory pathogens involved in nosocomial pneumonia, while bronchial concentrations remain low. Aminoglycoside concentrations in bronchial secretions cannot be used to predict alveolar concentrations. Low diffusibility can no longer be considered as a disadvantage of aminoglycosides for treating pneumonias.

Evaluation of the hemodynamic and respiratory effects of inverse ratio ventilation with a right ventricular ejection fraction catheter.

Pc-IRV has been shown to have respiratory advantages, compared with CPPV. However, the hemodynamic effects of this ventilation mode have not yet been fully elucidated. We used a REF catheter to monitor the hemodynamic changes in the RV. Fifteen ARDS patients were included in the study. The respiratory data showed a 35 percent decrease of PIP and a 32 percent decrease of VTi and VTe with Pc-IRV 4:1 compared with CPPV. Hemodynamic parameters showed a significant incrase in CI (17 percent) in Pc-IRV 4:1, without change in REF. Observing in retrospect the pressure-volume relationship of the RV, we could differentiate a preload (group 1) and an afterload dependent group of patients (group 2), CI was significantly different in the two groups as it rose only in the preload-dependent patients. RVEDVI showed a significant change in group 1, whereas this was absent in the second group. REF was maintained in switching ventilation from CPPV to Pc-IRV with increasing I:E ratio. Pc-IRV appears to be a good alternative ventilatory mode in comparison with CPPV in a selected group of patients with preload dependency (responders); in these patients with respiratory insufficiency, close hemodynamic monitoring is required to optimize ventilation, especially in relation to the hemodynamic effects.

Formic acid poisoning: case report and in vitro study of the hemolytic activity.

A case of fatal oral poisoning with formic acid resulting in shock, metabolic acidosis, and hemolysis is reported. The formic acid concentration on admission was 348 micrograms/mL, which, together with an increase in lactic acid, contributed to the metabolic acidosis. Because it has been suggested in the literature that formic acid might induce hemolysis via a direct cytotoxic action on the RBCs, an in vitro study was performed using human RBCs in saline, phosphate buffered saline, and plasma in order to define the mechanism of the hemolysis. These experiments indicate that the hemolysis is not a cytotoxic effect of formic acid but is related to the degree of acidity in itself.

Use of dopexamine hydrochloride in intensive care patients with low-output left ventricular heart failure.

The short- and long-term hemodynamic effects of intravenous dopexamine hydrochloride (Dopacard) were studied in 12 patients with low cardiac output left ventricular heart failure. In the short-term study, a dose of 4 micrograms/kg/min produced a 60% increase in cardiac output (p less than 0.001), a 30% increase in stroke volume (p less than 0.01), a 23% increase in heart rate (p less than 0.01) and a 39% decrease in systemic vascular resistance (p less than 0.001). In the long-term study, there was a sustained hemodynamic benefit after 8 hours of dopexamine hydrochloride infusion (mean dose 3.5 micrograms/kg/min). There was a 32% increase in cardiac output (p less than 0.001), an 18% increase in stroke volume (p less than 0.05), a 12% increase in heart rate (p less than 0.001) and a 30% decrease in systemic vascular resistance (p less than 0.01). After 48 hours of dopexamine hydrochloride infusion (mean dose 3.8 micrograms/kg/min), the hemodynamic effect was significant only for cardiac output (+20%, p less than 0.05) and for systemic vascular resistance (-26%, p less than 0.01). Thus, dopexamine hydrochloride has beneficial short-term hemodynamic effects in patients with low-output left ventricular heart failure and the benefit appears to diminish with long-term infusion.

Cardiac output-changes during hemodialysis with ultrafiltration.

Cardiovascular hemodynamics were studied noninvasively before, during and after hemodialysis with ultrafiltration in 18 patients on chronic hemodialysis. The cardiac output (CO) was determined by a continuous wave Doppler method. Overall, no major CO changes were seen (7.8 +/- 0.6 l/min post- versus 7.4 +/- 0.5 l/min pre-dialysis). Mean blood pressure rose slightly but significantly from 103 +/- 4 mmHg before to 113 +/- 3 mmHg after hemodialysis (p less than 0.01). Important interindividual differences in the intradialytic evolution of CO were observed. In patients with previous myocardial infarction or dilated cardiomyopathy (n = 12), CO rose significantly from 7.3 +/- 0.7 l/min before to 8.4 +/- 0.6 l/min after hemodialysis (p less than 0.05), while in patients without manifest myocardial disease (n = 6) CO decreased from 7.5 +/- 0.7 l/min to 6.6 +/- 0.9 l/min (NS). Comparison of the evolution of CO in both groups by variance analysis revealed a significant difference (p less than 0.01). It is concluded that, in response to hemodialysis with ultrafiltration, CO probably will increase in patients with myocardial infarction or congestive cardiomyopathy, but probably will decrease in patients without.

Comparison between ultrasonic and thermodilution cardiac output measurements in intensive care patients.

The reliability of ultrasonic cardiac output measurement was assessed using a commercial device that combines A-mode aortic root diameter determination and continuous wave (CW) Doppler flow velocity measurement in the ascending aorta. We compared this method with thermodilution (TD) cardiac output in 41 intensive care patients. Aortic root diameter measurement with A-mode was not possible in four (10%) patients. Using strictly defined criteria based upon our initial experience, we could not obtain acceptable CW Doppler flow signals in nine (22%) patients. Thus, ultrasonic cardiac output measurement was possible in 28 (68%) patients in whom there was an excellent correlation with cardiac output (r = 0.97; p less than .001). This study demonstrates that the transcutaneous CW Doppler method for measuring cardiac output is accurate and reliable in a limited percentage of ICU patients. Combining the CW Doppler with B-mode echocardiogram increases the applicability when an A-mode measurement is not possible.